| |
---|
Cell line: | MOLT-14 |
DSMZ no.: | ACC 437 |
Species: | human (Homo sapiens) |
Cell type: | T cell leukemia |
Origin: | established from the bone marrow of a 2-year-old girl with T-ALL (T cell acute lymphoblastic leukemia, FAB L2) at relapse in 1983; MOLT-13 (ACC 436) is a simultaneous sister cell line derived from the same patient sample with similar or identical features; by STR analysis, MOLT-13 and MOLT-14 are genetically identical |
Reference(s): | 14477 |
Biosafety level: | 1 |
Permissions and restrictions: | A |
| DSMZ Cell Culture Data: |
Morphology: | round, single cells growing in suspension; image; image; image |
Medium: | 90% RPMI 1640 + 10% h.i. FBS |
Subculture: | seed out at ca. 0.5-1 x 106 cells/ml; maintain at 0.5-1.5 x 106 cells/ml; split saturated culture 1:4 to 1:5 twice a week; culture medium becomes rarely acidic (yellow) |
Incubation: | at 37 °C with 5% CO2 |
Doubling time: | ca. 40-50 hours |
Harvest: | maximal density at ca. 2 x 106 cells/ml |
Storage: | frozen with 70% medium, 20% FBS, 10% DMSO |
| DSMZ Scientific Data: |
Mycoplasma: | negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
Immunology: | CD3 +, CD5 +, CD7 +, CD8 -, CD13 -, CD19 -; image |
Authenticity: | STR analysis according to the global standard ANSI/ATCC ASN-0002.1-2021 (2021) resulted in an authentic STR profile of the reference STR database, identical to that of MOLT-13 |
Cytogenetics: | human pseudodiploid karyotype with 8% polyploidy - 46(44-48)<2n>XX, der(17)t(17;17)(p13;q22.1) - resembles published karyotype - karyotypically identical to MOLT-13 |
Viruses: | ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV - |
Supplied as: | Delivery form | | Prices | | Frozen culture | | 450,- € | Growing culture (please inquire for exact delivery time) | | 900,- € | DNA isolated from cell line (25 µg) | | 560,- € | DNA isolated from cell line (5 µg) | | 140,- € | see price list |
| Print data sheet |